Why the study?
Is a significant platelet drop during heparin therapy associated with poor outcomes in patients with cerebrovascular ischemic disease?
Is a significant platelet drop during heparin therapy associated with poor outcomes in patients with cerebrovascular ischemic disease?
A significant platelet drop (≥40%) during heparin therapy for ischemic cerebrovascular disease is associated with poor clinical outcomes, highlighting the need for frequent platelet monitoring.
No takes yet. Share an insight, caveat, or question.
May warrant closer platelet monitoring in heparin-treated cerebrovascular disease; leaves open causality and need for prospective validation.
Ramirez‐Lassepas et al. (1984) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: